Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT00001756Completed
Study of Mast Cell Precursors
Healthy VolunteerMastocytosis
PrincipalinvestigatorStart date: 1997-12-03
NCT00890162Phase 2Completed
A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
AnaphylaxisAngioedemaBronchospasm+1 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National Institute of Allergy and Infectious Diseases (NIAID)

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00001756PrincipalInvestigator

Study of Mast Cell Precursors

Healthy VolunteerMastocytosis
Completed
NCT00050193PrincipalInvestigator

Cause and Natural Course of Pediatric-Onset Mastocytosis

Mastocytosis
Completed
NCT00890162Phase 2PrincipalInvestigator

A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis

AnaphylaxisAngioedemaBronchospasm+1 more
Completed

All 3 trials loaded